Humerickhouse R A, Besch H R, Gerzon K, Ruest L, Sutko J L, Emmick J T
Department of Pharmacology and Toxicology, Indiana University School of Medicine, Indianapolis 46202.
Mol Pharmacol. 1993 Aug;44(2):412-21.
Two novel natural ryanoids from extracts of the wood of Ryania speciosa Vahl were evaluated with sarcoplasmic reticulum (SR) vesicles for their binding affinities and their activating and deactivating effects on Ca2+ release channels. The new ryanoids, which are more polar than the known Ryania constituents ryanodine and didehydro-(9,21)-ryanodine, were purified using silica gel column chromatography and reverse phase high performance liquid chromatography. The new ryanoids were designated ester E and ester F, in keeping with nomenclature previously used in the literature. These compounds were identified by NMR spectroscopy and mass spectroscopy as C9ax-hydroxyryanodine and C8ax-hydroxy-C10-epi-dehydroryanodine, respectively. Binding of esters E and F to the high affinity (nanomolar Kd) site on SR Ca2+ release channels was determined from relative binding affinity assays using 6.7 nM [3H]ryanodine. Apparent Kd values of ryanodine, ester E, and ester F for binding to this domain on the skeletal muscle ryanodine receptor/SR Ca2+ release channel were 4.4 +/- 0.8, 65 +/- 10, and 257 +/- 53 nM, respectively (mean +/- standard deviation, four or more experiments). Apparent Kd values for cardiac muscle receptors were 0.51 +/- 0.01, 12 +/- 0.4, and 57 nM, respectively. As a functional indication of the effects of the ryanoids, channel-opening (activator) and channel-closing (deactivator) actions were assessed from the ability of the ryanoids to alter the rate of Ca2+ efflux from passively loaded skeletal muscle junctional sarcoplasmic reticular vesicles (JSRV). Activator actions among the ryanoids were similar, in that they exhibited apparently parallel concentration-effect curves, having a slope of 40% Ca2+ loss/decade increment in ryanoid concentration. Half-maximal values for activation (EC50 values) were 2.5, 63, and 43 microM for ryanodine, ester E, and ester F, respectively. Maximal channel opening by ester E was significantly less than that produced by the other ryanoids. The deactivator actions of the compounds on skeletal JSRV were dissimilar, in that their concentration-effect curves appeared not to be parallel. The quotient of the EC50 for deactivation and that for activation was taken as the concentration-coupling ratio (CCR). The CCR for ryanodine was 114 and that for ester F was 72, but the CCR for ester E was only 21. ATP-dependent Ca2+ accumulation by cardiac JSRV provided a second means to evaluate deactivator actions of the ryanoids. Results from cardiac JSRV assays were in general similar to those from skeletal JSRV assays.(ABSTRACT TRUNCATED AT 400 WORDS)
从刺桫椤(Ryania speciosa Vahl)木材提取物中分离出两种新型天然瑞诺生物碱,利用肌浆网(SR)囊泡评估了它们对Ca2+释放通道的结合亲和力以及激活和失活作用。这两种新型瑞诺生物碱比已知的刺桫椤成分瑞诺丁和双脱氢 - (9,21) - 瑞诺丁极性更强,通过硅胶柱色谱和反相高效液相色谱进行纯化。按照文献中先前使用的命名法,将这两种新型瑞诺生物碱分别命名为酯E和酯F。通过核磁共振光谱和质谱鉴定,这些化合物分别为C9ax - 羟基瑞诺丁和C8ax - 羟基 - C10 - 表 - 脱氢瑞诺丁。使用6.7 nM [3H]瑞诺丁,通过相对结合亲和力测定法确定酯E和酯F与SR Ca2+释放通道上高亲和力(纳摩尔Kd)位点的结合。瑞诺丁、酯E和酯F与骨骼肌瑞诺丁受体/SR Ca2+释放通道上该结构域结合的表观Kd值分别为4.4±0.8、65±10和257±53 nM(平均值±标准差,四个或更多实验)。心肌受体的表观Kd值分别为0.51±0.01、12±0.4和57 nM。作为瑞诺生物碱作用的功能指标,根据它们改变被动加载的骨骼肌连接肌浆网囊泡(JSRV)中Ca2+流出速率的能力,评估通道开放(激活剂)和通道关闭(失活剂)作用。瑞诺生物碱之间的激活剂作用相似,即它们呈现出明显平行的浓度 - 效应曲线,瑞诺生物碱浓度每增加十倍,Ca2+损失率为40%。瑞诺丁、酯E和酯F的激活半数最大值(EC50值)分别为2.5、63和43 microM。酯E引起的最大通道开放明显小于其他瑞诺生物碱。这些化合物对骨骼肌JSRV的失活作用不同,因为它们的浓度 - 效应曲线似乎不平行。失活的EC50与激活的EC50之商作为浓度偶联比(CCR)。瑞诺丁的CCR为114,酯F的CCR为72,但酯E的CCR仅为21。心肌JSRV的ATP依赖性Ca2+积累提供了另一种评估瑞诺生物碱失活作用的方法。心肌JSRV测定结果总体上与骨骼肌JSRV测定结果相似。(摘要截短至400字)